Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Observational, Open-Label, Single-Arm Study of Tysabri in Early Relapsing-Remitting Multiple Sclerosis in Anti-JCV Antibody Negative Patients

NCT01485003 is registered in ClinicalTrials.gov with Biogen as lead sponsor.

NCT NCT01485003
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01485003 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Observational, Open-Label, Single-Arm Study of Tysabri in Early Relapsing-Remitting Multiple Sclerosis in Anti-JCV Antibody Negative Patients
Lead sponsor
Biogen
Phase
Observational
Overall status
Completed
Start date
February 7, 2012
Completion date
November 26, 2018
Enrollment
231 (actual)
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

relapsing-remitting multiple sclerosis